The golden wind sends cool and harmonious spectrum, and the wind and sunshine welcome the distinguished guests. On November 9, 2018, the launch ceremony of Apollo's "Designated Cooperation Base of the National Human Genome Northern Research Center" was a complete success! Wang Lixin, Director of Longkou Economic Development Zone, Ning Shenglong, Deputy Director of the Management Committee of Longkou Economic Development Zone, Gao Jianjun, Sales Director and Genetic Consultant of National Human Genome Northern Research Center and Beijing Nuosai Genome Research Center Co., Ltd., National Human Genome Northern Research Center , Zhang Yanming, Director of Bioinformatics Analysis of Beijing Nuosai Genome Research Center Co., Ltd., Zhao Junyang, Director of Shandong Reporter Station of China Sankei Shimbun, Liu Ling, Deputy Station Chief of China Sankei Shimbun Shandong Reporter Station, Chairman of the Board of Directors of Apollo Group Fan Shenggang and Fan Kaiyu, general manager of Apollo Group, attended the event.

Wang Lixin, director of Longkou Economic Development Zone, pointed out: Big health is not only a big industry, a big wealth, but also a big people's livelihood and a big environment. It is also faced with big trends and big opportunities. From the central to local governments, they attach great importance to the development of big health enterprises, and issued a series of support The policy has brought many practical measures. From the national level, the 19th National Congress of the Communist Party of China put forward the strategy of implementing a healthy China, providing all-round and full-cycle health services for the people. From the perspective of the whole province, Shandong regards the medical care and health industry as one of the market industries that converts old and new kinetic energy. , and actively create a national demonstration province for the integration of medical care and elderly care. It is clearly stated that by 2022, the development goal of the medical and health care industry will reach the level of 10,000 people. From the perspective of Yantai, Yantai City has issued the city's medical and health industry development plan and opinions on further supporting the innovative development of the city's medical and health industry, reaching 100 billion yuan. The development goal of building an international life science innovation demonstration zone, and providing support from 15 aspects such as park planning and land supply. From the perspective of Longkou City, Longkou has natural famous manor houses such as mountains, water and sea, etc. The regional culture with characteristics such as breaking through the Guandong, the modern comprehensive transportation system is becoming more and more perfect, and the potential to accelerate the development of the big health industry is huge. Apollo is the first batch of enterprises to settle in the Longkou Development Zone, the first batch of high-tech enterprises and leading biopharmaceutical enterprises. , the company has cooperated with a number of experts, and has established a solid foundation for the company's high-quality development, focusing on the research of high-precision technologies such as active peptide factors, stem cell factors and emerging biomedical research and development. As a national genome research base approved by the Ministry of Science and Technology, the National Human Genome Northern Research Center has a world-class academic team, enterprise technology and equipment, and its technical level is internationally leading. The sufficient recognition of Apollo's R&D strength, market network, and brand reputation is also a full recognition of Longkou's investment environment, carrying capacity, and development potential. It is of great and far-reaching significance for high-quality development to drive the development of big health industry enterprises in our city and improve the health level of residents. It is hoped that both parties will take this unveiling as an opportunity to continuously deepen the coordinated development of industry, education and research, personnel training, scientific research, and social services. cooperation, benefit human health with the most cutting-edge science and technology, and help the development of our city's big health industry.

As the partners of this time, "National Human Genome Northern Research Center", "Sales Director of Beijing Nuosai Genome Research Center Co., Ltd.", and genetic counselor Gao Jianjun brought the blessing of General Manager Hou Quanmin: Apollo will "create a century-old brand, To be the industry of the century" is the corporate philosophy, with the brand culture of "challenging the limit and surpassing the dream", with the goal of "youth China, healthy human beings", and the enterprise spirit of "achieving the cause of human health" of the National Human Genome Northern Research Center perfectly fits . This joint effort is a beneficial move for the country to respond to the party and the country's national policy on national health, to improve the health of the entire population, and to promote individualized health management for the entire nation. This cooperation will make remarkable contributions to the national health cause of my country in the 21st century and the genetic testing industry to benefit the people, and work together to create brilliance!

Following the schedule, the host announced the official opening ceremony of the "Designated Cooperation Base of the National Human Genome Northern Research Center". Wang Lixin, Director of Longkou Economic Development Zone, Ning Shenglong, Deputy Director of Longkou Economic Development Zone Management Committee, National Human Genome Northern Research Center , Beijing Sino Genome Research Center Co., Ltd. Sales Director, Genetic Consultant Gao Jianjun, China Industry and Economics News Shandong Reporter Station Director Zhao Junyang, Apollo Group Chairman Fan Shenggang, Apollo Group General Manager Fan Kaiyu unveiled the ceremony.

When raising a glass to celebrate the welcome, genetic testing will prevent disease. Apollo will continue to take life extension and aging reversal as its mission, relying on its high-end scientific research platform and technological advantages, continue to climb to the peak of life science, continue the great cause of human life extension and aging reversal, and create a Chinese era for the world's biotechnology industry , to create a new era of human life and health.